Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome.

Renal involvement in Henoch-Schönlein purpura (HSP) constitutes a risk of end-stage renal disease (ESRD), especially in patients presenting with nephrotic syndrome.
The clinical courses of six patients (mean age 13.2 years; four boys and two girls) admitted from 2000 to 2007 with HSP and nephrotic syndrome were reviewed. Average follow-up was 44 months (28-59). Treatment protocols included oral prednisolone and in non-responders cyclosporin A, cyclophosphamide, mycophenolate mofetil or tacrolimus. Five patients were treated immediately after presentation of nephrotic syndrome/nephrotic range proteinuria (median 277 mg/m(2)/h). The last patient was treated locally with low-dose prednisolone (0.2-0.9 mg/kg/day) and 3 months of low-dose cyclophosphamide (1 mg/kg/day).
All five patients treated promptly with high-dose immunosuppressant had normal estimated glomerular filtration rate (eGFR) (median 159 ml/min/1.73 m(2)) at follow-up. One obtained complete remission, two had positive dipstick proteinuria and two needed angiotensin-converting enzyme inhibitors to stay normotensive. The patient receiving low-dose immunosuppression at onset progressed to ESRD 44 months later. At initial presentation eGFR, blood pressure, renal biopsy grading, proteinuric range and plasma albumin were similar in all patients.
Follow-up data from the patients suggest that an early aggressive immunosuppressive approach improves long-term renal outcome in HSP patients with nephrotic syndrome.
AuthorsR F Andersen, S Rubak, B Jespersen, S Rittig
JournalScandinavian journal of urology and nephrology (Scand J Urol Nephrol) Vol. 43 Issue 5 Pg. 409-15 ( 2009) ISSN: 1651-2065 [Electronic] England
PMID19921987 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Glucocorticoids
  • Immunosuppressive Agents
  • Adolescent
  • Biopsy
  • Child
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Glucocorticoids (administration & dosage)
  • Humans
  • Immunosuppression (methods)
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Nephrotic Syndrome (diagnosis, drug therapy, etiology)
  • Purpura, Schoenlein-Henoch (complications, diagnosis, drug therapy)
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: